Sector ยท Oct 2026
Healthcare stocks ranked by gap to the model's fair value
Faircurve's model values 159 healthcare stocks. 110 of them are ranked below by the gap between the model's fair value and the last close, as of 31 Oct 2026: 22 read as Undervalued, 80 as Fairly valued and 8 as Overvalued. The median gap across the ranked names is +1.7%. The widest gaps above the price are THC (+40.8%), IQV (+33.3%), CI (+29.8%). The widest below it are WAT (-25.7%), LLY (-20.9%), RGEN (-19.8%).
Valuations as of . Prices are the closes of 3 Nov 2026. The gap is the model's fair value against the price: a positive gap means the fair value is above the price. It states what the model concluded, not where the price goes next.
The ranking
| Rank | Company | Last close | Model fair value | Gap | Model verdict | Quality score | Market value |
|---|---|---|---|---|---|---|---|
| 1 | THC Tenet Healthcare CorporationMedical Care Facilities | $266.69 | $375.62 | +40.8% | Undervalued | 65 | $22.0B |
| 2 | IQV IQVIA Holdings Inc.Diagnostics & Research | $262.59 | $350.11 | +33.3% | Undervalued | 55 | $44.1B |
| 3 | CI Cigna CorporationHealthcare Plans | $295.44 | $383.45 | +29.8% | Undervalued | 69 | $78.8B |
| 4 | CRL Charles River Laboratories International, Inc.Diagnostics & Research | $351.87 | $450.20 | +27.9% | Undervalued | 50 | $17.3B |
| 5 | ENOV Enovis CorporationMedical Devices | $20.89 | $26.53 | +27.0% | Undervalued | 54 | $1.1B |
| 6 | BMRN BioMarin Pharmaceutical Inc.Biotechnology | $55.66 | $70.40 | +26.5% | Undervalued | 56 | $11.3B |
| 7 | KRYS Krystal Biotech, Inc.Biotechnology | $305.03 | $384.08 | +25.9% | Undervalued | 81 | $9.8B |
| 8 | FTRE Fortrea Holdings Inc.Biotechnology | $20.95 | $26.04 | +24.3% | Undervalued | 41 | $2.0B |
| 9 | ALGN Align Technology, Inc.Medical Devices | $151.58 | $188.05 | +24.1% | Undervalued | 75 | $10.6B |
| 10 | CNC Centene Corp.Healthcare Plans | $67.48 | $82.97 | +23.0% | Undervalued | 55 | $33.9B |
| 11 | VTRS Viatris Inc.Specialty & Generic Drug Manufacturers | $18.92 | $23.11 | +22.1% | Undervalued | 28 | $21.9B |
| 12 | LH Labcorp Holdings Inc.Diagnostics & Research | $353.92 | $429.61 | +21.4% | Undervalued | 54 | $29.3B |
| 13 | DGX Quest Diagnostics IncorporatedDiagnostics & Research | $247.06 | $298.39 | +20.8% | Undervalued | 73 | $27.8B |
| 14 | HCA HCA Healthcare, Inc.Medical Care Facilities | $462.86 | $558.28 | +20.6% | Undervalued | 68 | $102.4B |
| 15 | INCY Incyte CorporationBiotechnology | $117.59 | $141.04 | +19.9% | Undervalued | 70 | $24.4B |
| 16 | ADMA ADMA Biologics, Inc.Biotechnology | $11.11 | $13.32 | +19.9% | Undervalued | 67 | $2.6B |
| 17 | ICUI ICU Medical, Inc.Medical Instruments & Supplies | $161.83 | $193.63 | +19.7% | Undervalued | 49 | $4.1B |
| 18 | EHC Encompass Health CorporationMedical Care Facilities | $134.79 | $159.65 | +18.4% | Undervalued | 67 | $13.4B |
| 19 | CTKB Cytek Biosciences, Inc.Medical Devices | $5.96 | $7.02 | +17.8% | Undervalued | 51 | $797M |
| 20 | RVTY Revvity, Inc.Diagnostics & Research | $163.48 | $188.77 | +15.5% | Undervalued | 47 | $17.5B |
| 21 | PODD Insulet Corp.Medical Devices | $154.86 | $178.47 | +15.2% | Undervalued | 70 | $10.4B |
| 22 | GMED Globus Medical, Inc.Medical Devices | $79.58 | $91.57 | +15.1% | Undervalued | 78 | $10.5B |
| 23 | BMY Bristol-Myers Squibb CompanyGeneral Drug Manufacturers | $61.71 | $70.65 | +14.5% | Fairly valued | 34 | $127.6B |
| 24 | RMD ResMed Inc.Medical Instruments & Supplies | $227.08 | $259.22 | +14.2% | Fairly valued | 77 | $32.3B |
| 25 | DVA DaVita Inc.Medical Care Facilities | $182.17 | $207.11 | +13.7% | Fairly valued | 72 | $12.0B |
| 26 | PFE Pfizer Inc.General Drug Manufacturers | $30.00 | $34.04 | +13.5% | Fairly valued | 32 | $174.0B |
| 27 | VCEL Vericel CorporationBiotechnology | $41.09 | $46.61 | +13.4% | Fairly valued | 65 | $2.1B |
| 28 | BRKR Bruker CorporationMedical Devices | $56.50 | $63.61 | +12.6% | Fairly valued | 46 | $8.7B |
| 29 | WAY Waystar Holding Corp.Healthcare Information Services | $27.66 | $30.97 | +12.0% | Fairly valued | 52 | $5.4B |
| 30 | ADUS Addus HomeCare CorporationMedical Care Facilities | $126.55 | $141.59 | +11.9% | Fairly valued | 68 | $2.3B |
| 31 | COO The Cooper Companies, Inc.Medical Instruments & Supplies | $60.83 | $68.01 | +11.8% | Fairly valued | 55 | $11.3B |
| 32 | LIVN LivaNova PLCMedical Devices | $79.90 | $88.46 | +10.7% | Fairly valued | 66 | $4.3B |
| 33 | HIMS Hims & Hers Health, Inc.Medical Care Facilities | $25.70 | $28.40 | +10.5% | Fairly valued | 59 | $6.2B |
| 34 | MEDP Medpace Holdings, Inc.Diagnostics & Research | $663.49 | $732.27 | +10.4% | Fairly valued | 82 | $18.2B |
| 35 | OMCL Omnicell, Inc.Healthcare Information Services | $35.46 | $38.92 | +9.8% | Fairly valued | 65 | $1.7B |
| 36 | BSX Boston Scientific CorporationMedical Devices | $43.50 | $47.54 | +9.3% | Fairly valued | 61 | $60.8B |
| 37 | ZBH Zimmer Biomet Holdings, Inc.Medical Devices | $97.06 | $105.50 | +8.7% | Fairly valued | 41 | $18.0B |
| 38 | ANIP ANI Pharmaceuticals, Inc.Specialty & Generic Drug Manufacturers | $72.28 | $78.25 | +8.3% | Fairly valued | 81 | $1.7B |
| 39 | VIR Vir Biotechnology, Inc.Biotechnology | $11.22 | $12.12 | +8.0% | Fairly valued | 42 | $1.9B |
| 40 | ELV Elevance Health Inc.Healthcare Plans | $413.75 | $445.90 | +7.8% | Fairly valued | 57 | $91.1B |
| 41 | AMGN Amgen Inc.General Drug Manufacturers | $461.26 | $491.10 | +6.5% | Fairly valued | 67 | $251.9B |
| 42 | CHE Chemed CorporationMedical Care Facilities | $533.65 | $563.60 | +5.6% | Fairly valued | 82 | $7.0B |
| 43 | UTHR United Therapeutics CorporationBiotechnology | $601.32 | $634.32 | +5.5% | Fairly valued | 66 | $25.7B |
| 44 | NEO NeoGenomics, Inc.Diagnostics & Research | $16.83 | $17.74 | +5.4% | Fairly valued | 42 | $2.3B |
| 45 | AMRX Amneal Pharmaceuticals, Inc.Specialty & Generic Drug Manufacturers | $20.21 | $21.22 | +5.0% | Fairly valued | 59 | $6.9B |
| 46 | CON Concentra Group Holdings Parent, Inc.Medical Care Facilities | $40.15 | $42.06 | +4.8% | Fairly valued | 70 | $5.1B |
| 47 | OPCH Option Care Health, Inc.Medical Care Facilities | $31.77 | $33.23 | +4.6% | Fairly valued | 62 | $4.8B |
| 48 | A Agilent Technologies, Inc.Diagnostics & Research | $175.46 | $183.45 | +4.6% | Fairly valued | 61 | $49.3B |
| 49 | ZTS Zoetis Inc.Specialty & Generic Drug Manufacturers | $82.99 | $86.45 | +4.2% | Fairly valued | 70 | $32.9B |
| 50 | ABBV AbbVie Inc.General Drug Manufacturers | $286.00 | $297.68 | +4.1% | Fairly valued | 78 | $521.1B |
| 51 | BIIB Biogen Inc.General Drug Manufacturers | $248.93 | $258.65 | +3.9% | Fairly valued | 48 | $37.5B |
| 52 | HSIC Henry Schein, Inc.Medical Distribution | $82.50 | $85.40 | +3.5% | Fairly valued | 53 | $9.5B |
| 53 | CVS CVS Health Corp.Healthcare Plans | $91.41 | $93.61 | +2.4% | Fairly valued | 45 | $115.4B |
| 54 | CERT Certara, Inc.Healthcare Information Services | $10.87 | $11.11 | +2.2% | Fairly valued | 42 | $1.7B |
| 55 | MTD Mettler-Toledo International Inc.Diagnostics & Research | $1,698.04 | $1,727.57 | +1.7% | Fairly valued | 70 | $33.6B |
| 56 | INSM Insmed IncorporatedBiotechnology | $104.44 | $106.20 | +1.7% | Fairly valued | 46 | $24.6B |
| 57 | GEHC GE HealthCare Technologies Inc.Medical Devices | $80.66 | $81.91 | +1.5% | Fairly valued | 49 | $34.6B |
| 58 | REGN Regeneron Pharmaceuticals, Inc.Biotechnology | $973.36 | $985.42 | +1.2% | Fairly valued | 51 | $95.5B |
| 59 | HSTM HealthStream, Inc.Healthcare Information Services | $31.67 | $32.00 | +1.0% | Fairly valued | 65 | $1.0B |
| 60 | DXCM DexCom, Inc.Medical Devices | $82.97 | $83.81 | +1.0% | Fairly valued | 74 | $31.1B |
| 61 | ABT Abbott LaboratoriesMedical Devices | $109.40 | $109.39 | 0.0% | Fairly valued | 58 | $183.8B |
| 62 | PGNY Progyny, Inc.Healthcare Plans | $29.06 | $29.00 | -0.2% | Fairly valued | 86 | $2.2B |
| 63 | UNH UnitedHealth Group IncorporatedHealthcare Plans | $404.44 | $403.04 | -0.3% | Fairly valued | 66 | $365.3B |
| 64 | NBIX Neurocrine Biosciences, Inc.Biotechnology | $164.85 | $162.09 | -1.7% | Fairly valued | 68 | $14.9B |
| 65 | DOCS Doximity, Inc.Healthcare Information Services | $32.60 | $32.04 | -1.7% | Fairly valued | 83 | $5.8B |
| 66 | BDX Becton, Dickinson and CompanyMedical Instruments & Supplies | $198.17 | $194.07 | -2.1% | Fairly valued | 45 | $53.9B |
| 67 | LNTH Lantheus Holdings, Inc.Specialty & Generic Drug Manufacturers | $100.80 | $98.59 | -2.2% | Fairly valued | 70 | $6.6B |
| 68 | TMO Thermo Fisher Scientific Inc.Diagnostics & Research | $698.34 | $682.83 | -2.2% | Fairly valued | 52 | $257.7B |
| 69 | MOH Molina Healthcare, Inc.Healthcare Plans | $207.85 | $202.97 | -2.3% | Fairly valued | 52 | $10.7B |
| 70 | HAE Haemonetics CorporationMedical Devices | $120.28 | $117.17 | -2.6% | Fairly valued | 70 | $5.4B |
| 71 | MMSI Merit Medical Systems, Inc.Medical Instruments & Supplies | $84.16 | $81.34 | -3.4% | Fairly valued | 65 | $5.1B |
| 72 | STE STERIS plcMedical Specialties | $231.35 | $222.57 | -3.8% | Fairly valued | 61 | $22.1B |
| 73 | ROIV Roivant Sciences Ltd.Biotechnology | $36.04 | $34.62 | -3.9% | Fairly valued | 18 | $26.7B |
| 74 | RDNT RadNet, Inc.Diagnostics & Research | $73.18 | $69.84 | -4.6% | Fairly valued | 51 | $5.8B |
| 75 | USPH U.S. Physical Therapy, Inc.Medical Care Facilities | $84.74 | $80.74 | -4.7% | Fairly valued | 64 | $1.3B |
| 76 | STAA STAAR Surgical CompanyMedical Instruments & Supplies | $25.17 | $23.97 | -4.8% | Fairly valued | 55 | $1.2B |
| 77 | SOLV Solventum CorporationMedical Instruments & Supplies | $84.76 | $80.57 | -4.9% | Fairly valued | 50 | $13.8B |
| 78 | VRTX Vertex Pharmaceuticals IncorporatedBiotechnology | $530.76 | $504.07 | -5.0% | Fairly valued | 62 | $141.7B |
| 79 | EXEL Exelixis, Inc.Biotechnology | $72.31 | $68.28 | -5.6% | Fairly valued | 73 | $17.4B |
| 80 | HCSG Healthcare Services Group, Inc.Medical Care Facilities | $25.57 | $24.09 | -5.8% | Fairly valued | 83 | $1.7B |
| 81 | GILD Gilead Sciences, Inc.General Drug Manufacturers | $167.47 | $157.69 | -5.8% | Fairly valued | 41 | $211.6B |
| 82 | WST West Pharmaceutical Services, Inc.Medical Instruments & Supplies | $406.99 | $383.18 | -5.9% | Fairly valued | 58 | $29.0B |
| 83 | ITGR Integer Holdings CorporationMedical Devices | $126.55 | $119.02 | -6.0% | Fairly valued | 43 | $4.3B |
| 84 | MDT Medtronic PlcMedical Devices | $98.88 | $92.90 | -6.0% | Fairly valued | 50 | $123.5B |
| 85 | ENSG The Ensign Group, Inc.Medical Care Facilities | $182.21 | $170.48 | -6.4% | Fairly valued | 59 | $10.6B |
| 86 | BIO Bio-Rad Laboratories, Inc.Medical Devices | $374.91 | $350.46 | -6.5% | Fairly valued | 38 | $10.0B |
| 87 | ATR AptarGroup, Inc.Medical Instruments & Supplies | $142.31 | $132.22 | -7.1% | Fairly valued | 57 | $8.7B |
| 88 | DHR Danaher CorporationDiagnostics & Research | $230.11 | $213.76 | -7.1% | Fairly valued | 41 | $163.3B |
| 89 | BAX Baxter International Inc.Medical Instruments & Supplies | $25.49 | $23.62 | -7.3% | Fairly valued | 32 | $11.9B |
| 90 | CORT Corcept Therapeutics IncorporatedPharmaceuticals | $81.93 | $75.67 | -7.6% | Fairly valued | 62 | $8.8B |
| 91 | PEN Penumbra, Inc.Medical Devices | $320.02 | $291.62 | -8.9% | Fairly valued | 64 | $12.6B |
| 92 | UFPT UFP Technologies, Inc.Medical Devices | $280.32 | $253.80 | -9.5% | Fairly valued | 74 | $2.2B |
| 93 | LMAT LeMaitre Vascular, Inc.Medical Instruments & Supplies | $80.60 | $72.73 | -9.8% | Fairly valued | 69 | $1.9B |
| 94 | ALKS Alkermes plcSpecialty & Generic Drug Manufacturers | $45.69 | $40.62 | -11.1% | Fairly valued | 43 | $7.6B |
| 95 | HUM Humana Inc.Healthcare Plans | $417.87 | $371.37 | -11.1% | Fairly valued | 38 | $49.8B |
| 96 | TECH Bio-Techne CorporationBiotechnology | $72.66 | $64.04 | -11.9% | Fairly valued | 55 | $11.4B |
| 97 | PTCT PTC Therapeutics, Inc.Biotechnology | $68.12 | $59.76 | -12.3% | Fairly valued | 37 | $5.0B |
| 98 | MRK Merck & Co., Inc.General Drug Manufacturers | $144.67 | $125.88 | -13.0% | Fairly valued | 40 | $368.9B |
| 99 | RCUS Arcus Biosciences, Inc.Biotechnology | $18.91 | $16.43 | -13.1% | Fairly valued | 31 | $2.3B |
| 100 | NEOG Neogen CorporationMedical Devices | $12.10 | $10.47 | -13.5% | Fairly valued | 26 | $2.6B |
| 101 | EW Edwards Lifesciences CorporationMedical Devices | $95.19 | $81.97 | -13.9% | Overvalued | 59 | $53.0B |
| 102 | JNJ Johnson & JohnsonGeneral Drug Manufacturers | $266.17 | $227.23 | -14.6% | Fairly valued | 67 | $657.7B |
| 103 | SYK Stryker CorporationMedical Devices | $310.55 | $264.06 | -15.0% | Fairly valued | 55 | $111.9B |
| 104 | MRNA Moderna, Inc.Biotechnology | $228.44 | $194.13 | -15.0% | Overvalued | 34 | $88.5B |
| 105 | IDXX IDEXX Laboratories, Inc.Diagnostics & Research | $672.04 | $547.59 | -18.5% | Overvalued | 79 | $43.4B |
| 106 | ILMN Illumina, Inc.Diagnostics & Research | $238.21 | $191.98 | -19.4% | Overvalued | 52 | $35.6B |
| 107 | ISRG Intuitive Surgical, Inc.Medical Instruments & Supplies | $440.75 | $354.62 | -19.5% | Overvalued | 70 | $152.6B |
| 108 | RGEN Repligen CorporationMedical Instruments & Supplies | $178.27 | $142.95 | -19.8% | Overvalued | 60 | $11.2B |
| 109 | LLY Eli Lilly and CompanyGeneral Drug Manufacturers | $1,409.38 | $1,114.95 | -20.9% | Overvalued | 71 | $1.33T |
| 110 | WAT Waters CorporationDiagnostics & Research | $459.90 | $341.64 | -25.7% | Overvalued | 48 | $45.4B |
The Global Pulse
Faircurve's market note, in your inbox each market day
The Global Pulse is Faircurve's note after each US session: what moved, in plain words. No account needed.
Valued but not ranked
These 49 names are valued but not ranked, for one of four reasons: the model grades the evidence as low or has not graded it yet, the inputs are under review, the gap is wider than 60%, or the valuation is more than three weeks old. The numbers are shown for reference.
| Company | Last close | Model fair value | Gap | Why it is not ranked | Quality score | Market value |
|---|---|---|---|---|---|---|
| ACAD Acadia Pharmaceuticals Inc.Biotechnology | $20.57 | $20.65 | +0.4% | Low evidence grade | $3.5B | |
| ACHC Acadia Healthcare Company, Inc.Medical Care Facilities | $29.62 | $36.86 | +24.4% | Low evidence grade | 48 | $2.8B |
| AHCO AdaptHealth Corp.Medical Devices | $6.28 | $5.97 | -4.9% | Low evidence grade | 37 | $792M |
| ALNY Alnylam Pharmaceuticals, Inc.Biotechnology | $159.89 | $165.50 | +3.5% | Low evidence grade | $22.1B | |
| AMN AMN Healthcare Services, Inc.Medical Care Facilities | $45.30 | $52.07 | +14.9% | Low evidence grade | 67 | $1.8B |
| AMPH Amphastar Pharmaceuticals, Inc.Specialty & Generic Drug Manufacturers | $27.12 | $27.90 | +2.9% | Low evidence grade | $1.2B | |
| AORT Artivion, Inc.Medical Devices | $23.71 | $21.20 | -10.6% | Low evidence grade | 50 | $1.1B |
| ARWR Arrowhead Pharmaceuticals, Inc.Biotechnology | $59.53 | $49.37 | -17.1% | Data under review | 49 | $8.5B |
| ASTH Astrana Health, Inc.Medical Care Facilities | $36.73 | $43.84 | +19.4% | Low evidence grade | 64 | $1.8B |
| AVTR Avantor, Inc.Medical Instruments & Supplies | $15.59 | $19.12 | +22.6% | Low evidence grade | 51 | $10.9B |
| BTSG BrightSpring Health Services, Inc. Common StockHealthcare Information Services | $69.84 | $62.98 | -9.8% | Low evidence grade | 78 | $13.2B |
| CAH Cardinal Health, Inc.Medical Distribution | $252.94 | $257.62 | +1.9% | Low evidence grade | 83 | $58.0B |
| CNMD CONMED CorporationMedical Devices | $47.23 | $58.55 | +24.0% | Low evidence grade | 61 | $1.3B |
| COLL Collegium Pharmaceutical, Inc.Specialty & Generic Drug Manufacturers | $23.73 | $23.98 | +1.1% | Low evidence grade | $775M | |
| COR Cencora, Inc.Medical Distribution | $340.50 | $345.73 | +1.5% | Low evidence grade | 74 | $63.1B |
| CYTK Cytokinetics, IncorporatedBiotechnology | $62.31 | $52.67 | -15.5% | Low evidence grade | 50 | $8.8B |
| ELAN Elanco Animal Health IncorporatedSpecialty & Generic Drug Manufacturers | $24.57 | $22.21 | -9.6% | Low evidence grade | 43 | $11.5B |
| EMBC Embecta Corp.Medical Instruments & Supplies | $6.08 | $4.45 | -26.8% | Low evidence grade | 65 | $354M |
| GKOS Glaukos CorporationMedical Devices | $233.04 | $220.17 | -5.5% | Data under review | 54 | $14.1B |
| HALO Halozyme Therapeutics, Inc.Biotechnology | $128.62 | $134.12 | +4.3% | Low evidence grade | 82 | $14.9B |
| HQY HealthEquity, Inc.Healthcare Information Services | $102.03 | $111.17 | +9.0% | Low evidence grade | 67 | $8.5B |
| HRMY Harmony Biosciences Holdings, Inc.Biotechnology | $37.02 | $38.98 | +5.3% | Low evidence grade | $2.3B | |
| IART Integra LifeSciences Holdings CorporationMedical Devices | $13.63 | $9.30 | -31.8% | Low evidence grade | 57 | $992M |
| INDV Indivior Pharmaceuticals IncSpecialty & Generic Drug Manufacturers | $36.28 | $35.52 | -2.1% | Low evidence grade | $4.4B | |
| INSP Inspire Medical Systems, Inc.Medical Devices | $61.90 | $68.30 | +10.3% | Low evidence grade | $2.0B | |
| INVA Innoviva, Inc.Biotechnology | $20.93 | $22.92 | +9.5% | Low evidence grade | 63 | $1.5B |
| JAZZ Jazz Pharmaceuticals plcBiotechnology | $229.74 | $256.45 | +11.6% | Low evidence grade | 64 | $14.0B |
| LGND Ligand Pharmaceuticals IncorporatedBiotechnology | $313.52 | $297.44 | -5.1% | Low evidence grade | 47 | $6.4B |
| MCK McKesson CorporationMedical Distribution | $999.62 | $997.18 | -0.2% | Low evidence grade | 82 | $116.0B |
| MD Pediatrix Medical Group, Inc.Medical Care Facilities | $30.60 | $32.25 | +5.4% | Low evidence grade | 64 | $2.4B |
| NHC National HealthCare CorporationMedical Care Facilities | $205.83 | $255.41 | +24.1% | Low evidence grade | 62 | $3.2B |
| NVST Envista Holdings CorpMedical Instruments & Supplies | $24.77 | $27.44 | +10.8% | Low evidence grade | 61 | $3.8B |
| OGN Organon & Co.General Drug Manufacturers | $13.85 | $13.90 | +0.4% | Low evidence grade | $3.6B | |
| PAHC Phibro Animal Health CorporationSpecialty & Generic Drug Manufacturers | $37.65 | $37.94 | +0.8% | Low evidence grade | 56 | $1.6B |
| PBH Prestige Consumer Healthcare Inc.Pharmaceuticals | $49.54 | $45.28 | -8.6% | Low evidence grade | 51 | $2.3B |
| PCRX Pacira BioSciences, Inc.Specialty & Generic Drug Manufacturers | $36.39 | $36.66 | +0.7% | Low evidence grade | $1.5B | |
| PTGX Protagonist Therapeutics, Inc.Biotechnology | $140.24 | $167.40 | +19.4% | Low evidence grade | 63 | $9.4B |
| QDEL QuidelOrtho CorporationMedical Specialties | $14.09 | $6.35 | -54.9% | Low evidence grade | 37 | $909M |
| SHC Sotera Health CompanyDiagnostics & Research | $16.03 | $27.14 | +69.3% | Gap wider than 60% | 55 | $5.2B |
| SRPT Sarepta Therapeutics, Inc.Biotechnology | $18.54 | $22.32 | +20.4% | Low evidence grade | 49 | $2.0B |
| SUPN Supernus Pharmaceuticals, Inc.Specialty & Generic Drug Manufacturers | $28.15 | $42.16 | +49.8% | Low evidence grade | $2.4B | |
| TFX Teleflex IncorporatedMedical Instruments & Supplies | $139.95 | $142.86 | +2.1% | Low evidence grade | 59 | $5.9B |
| TGTX TG Therapeutics, Inc.Biotechnology | $60.75 | $70.94 | +16.8% | Low evidence grade | 56 | $9.4B |
| TMDX TransMedics Group, Inc.Medical Devices | $67.34 | $78.59 | +16.7% | Low evidence grade | 53 | $2.3B |
| TNDM Tandem Diabetes Care, Inc.Medical Devices | $17.65 | $19.14 | +8.4% | Low evidence grade | 51 | $1.3B |
| UHS Universal Health Services, Inc.Medical Care Facilities | $177.13 | $284.60 | +60.7% | Gap wider than 60% | 42 | $9.1B |
| VCYT Veracyte, Inc.Diagnostics & Research | $50.29 | $50.15 | -0.3% | Low evidence grade | $4.0B | |
| XNCR Xencor, Inc.Biotechnology | $30.64 | $33.00 | +7.7% | Data under review | 37 | $2.2B |
| XRAY DENTSPLY SIRONA Inc.Medical Instruments & Supplies | $9.73 | $17.50 | +79.9% | Gap wider than 60% | 56 | $1.9B |
Healthcare industries
Other sectors
- Basic Materials 77
- Communication Services 41
- Consumer Cyclical 186
- Consumer Defensive 80
- Energy 72
- Financial Services 226
- Industrials 216
- Real Estate 109
- Technology 223
- Utilities 56